A detailed history of Hilltop Holdings Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Hilltop Holdings Inc. holds 7,328 shares of LLY stock, worth $5.83 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
7,328
Previous 3,356 118.36%
Holding current value
$5.83 Million
Previous $3.04 Million 113.69%
% of portfolio
0.42%
Previous 0.36%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $3.07 Million - $3.81 Million
3,972 Added 118.36%
7,328 $6.49 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $742,991 - $931,766
-1,025 Reduced 23.4%
3,356 $3.04 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $129,099 - $172,717
218 Added 5.24%
4,381 $3.41 Million
Q4 2023

Feb 09, 2024

SELL
$525.19 - $619.13 $82,980 - $97,822
-158 Reduced 3.66%
4,163 $2.43 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $120,411 - $166,006
277 Added 6.85%
4,321 $2.32 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $131,527 - $175,867
375 Added 10.22%
4,044 $1.9 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $57,777 - $67,856
-186 Reduced 4.82%
3,669 $1.26 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $233,123 - $271,635
725 Added 23.16%
3,855 $1.41 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $126,004 - $143,594
-425 Reduced 11.95%
3,130 $1.01 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $88,078 - $103,417
316 Added 9.76%
3,555 $1.15 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $76,274 - $94,789
-325 Reduced 9.12%
3,239 $927,000
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $70,378 - $87,339
-313 Reduced 8.07%
3,564 $984,000
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $83,100 - $102,266
375 Added 10.71%
3,877 $896,000
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $29,790 - $38,534
165 Added 4.94%
3,502 $804,000
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $78,216 - $101,254
476 Added 16.64%
3,337 $623,000
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $175,990 - $232,877
1,349 Added 89.22%
2,861 $483,000
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $36,408 - $42,113
249 Added 19.71%
1,512 $224,000
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $172,298 - $207,359
1,263 New
1,263 $208,000
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $282,512 - $324,236
-3,732 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $276,951 - $326,923
3,732 New
3,732 $288,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hilltop Holdings Inc. Portfolio

Follow Hilltop Holdings Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hilltop Holdings Inc. with notifications on news.